HLA-DP and bone marrow transplantation: DP-incompatibility and severe acute graft versus host disease. 1987

N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
Tissue Typing Laboratory, State University Hospital, Copenhagen, Denmark.

Thirteen recipients of HLA-haploidentical, DR compatible bone marrow (BM) and the corresponding BM donors were HLA-DP typed using primed lymphocyte typing (PLT). Severe acute GVHD (greater than or equal to grade 2) developed within 3 months after BM-transplantation in all of eight recipients of DP incompatible BM, but in none of five recipients of DP-compatible BM. This difference was highly significant (p less than 0.001, Fisher's exact test). Moreover, severe acute GVHD was significantly increased in recipients of haploidentical, DR compatible, but DP incompatible BM as compared to severe acute GVHD in 88 recipients of HLA-identical BM (p less than 0.0001). In contrast, there was no difference in acute GVHD between recipients of haploidentical, DR and DP compatible BM and recipients of HLA-identical BM. The data presented here provide strong evidence for the first time that HLA-DP antigens play a role as transplantation antigens.

UI MeSH Term Description Entries
D006086 Graft vs Host Disease The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION. Graft-Versus-Host Disease,Homologous Wasting Disease,Runt Disease,Graft-vs-Host Disease,Disease, Graft-Versus-Host,Disease, Graft-vs-Host,Disease, Homologous Wasting,Disease, Runt,Diseases, Graft-Versus-Host,Diseases, Graft-vs-Host,Graft Versus Host Disease,Graft-Versus-Host Diseases,Graft-vs-Host Diseases
D006239 Haplotypes The genetic constitution of individuals with respect to one member of a pair of allelic genes, or sets of genes that are closely linked and tend to be inherited together such as those of the MAJOR HISTOCOMPATIBILITY COMPLEX. Haplotype
D006681 HLA-D Antigens Human immune-response or Class II antigens found mainly, but not exclusively, on B-lymphocytes and produced from genes of the HLA-D locus. They are extremely polymorphic families of glycopeptides, each consisting of two chains, alpha and beta. This group of antigens includes the -DR, -DQ and -DP designations, of which HLA-DR is most studied; some of these glycoproteins are associated with certain diseases, possibly of immune etiology. Antigens, HLA-D,Class II Human Antigens,HLA-Dw Antigens,Human Class II Antigens,Ia-Like Antigens, Human,Immune Response-Associated Antigens, Human,Immune-Associated Antigens, Human,Immune-Response Antigens, Human,HLA-D,HLA-Dw,Immune Response Associated Antigens, Human,Antigens, HLA D,Antigens, HLA-Dw,Antigens, Human Ia-Like,Antigens, Human Immune-Associated,Antigens, Human Immune-Response,HLA D Antigens,HLA Dw Antigens,Human Ia-Like Antigens,Human Immune-Associated Antigens,Human Immune-Response Antigens,Ia Like Antigens, Human,Immune Associated Antigens, Human,Immune Response Antigens, Human
D006682 HLA-DP Antigens A group of the D-related HLA antigens (human) found to differ from the DR antigens in genetic locus and therefore inheritance. These antigens are polymorphic glycoproteins comprising alpha and beta chains and are found on lymphoid and other cells, often associated with certain diseases. HLA-PL Antigens,HLA-SB Antigens,HLA-DP,HLA-PL,HLA-SB,Antigens, HLA-DP,Antigens, HLA-PL,Antigens, HLA-SB,HLA DP Antigens,HLA PL Antigens,HLA SB Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014181 Transplantation Immunology A general term for the complex phenomena involved in allo- and xenograft rejection by a host and graft vs host reaction. Although the reactions involved in transplantation immunology are primarily thymus-dependent phenomena of cellular immunity, humoral factors also play a part in late rejection. Immunology, Transplantation
D016026 Bone Marrow Transplantation The transference of BONE MARROW from one human or animal to another for a variety of purposes including HEMATOPOIETIC STEM CELL TRANSPLANTATION or MESENCHYMAL STEM CELL TRANSPLANTATION. Bone Marrow Cell Transplantation,Grafting, Bone Marrow,Transplantation, Bone Marrow,Transplantation, Bone Marrow Cell,Bone Marrow Grafting

Related Publications

N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
November 1986, Transplantation,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
August 1991, Transplantation,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
September 1999, British journal of haematology,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
April 2016, Haematologica,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
July 1984, [Rinsho ketsueki] The Japanese journal of clinical hematology,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
November 1983, Canadian Medical Association journal,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
January 1989, Current opinion in immunology,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
May 1993, The New England journal of medicine,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
January 2011, Frontiers in immunology,
N Odum, and P Platz, and B K Jakobsen, and C M Petersen, and N Jacobsen, and J Møller, and L P Ryder, and L Lamm, and A Svejgaard
September 2015, The Lancet. Oncology,
Copied contents to your clipboard!